期刊文献+

BED捕获酶联免疫法检测广西某吸毒监测哨点HIV新近感染率 被引量:3

Detection of HIV incidence using BED capture enzyme immunoassay at a surveillance sentinel site of injection drug users in Guangxi
原文传递
导出
摘要 目的了解广西某吸毒监测哨点注射吸毒人群(injection drugusers,IDU)的HIV新近感染情况,估算HIV新近感染率。方法对广西某吸毒监测哨点2005—2007年787份血清样本进行监测,以酶联免疫吸附试验(ELISA)筛检出168份HIV-1阳性样本,再经BED捕获酶联免疫法(BED capture enzyme immunoassay,BED.CEIA)检测出其中新近感染的样本共17份,获得该人群HIV-1的新近感染率。结果787份监测样本中共筛检出HIV-1确认阳性样本168份,新近感染样本17份。该哨点2005—2007年HIV感染率分别为23.06%(92/399)、21.90%(46/210)、16.85%(30/178),新近感染率分别为7.41%、6.94%、3.12%。结论在广西某吸毒监测哨点IDU中,2005—2007年HIV新近感染率绝对数值有所降低,已发现的HIV感染者可能部分为既往感染者。 Objective To detect recent HIV incidence of injection drug users (IDU) from a surveillance site of IDU in Guangxi and estimate HIV incidence. Methods 787 Samples from a IDU surveillance sentinel site in Guangxi (2005-2007) were collected for ELISA and 168 were HIV-1 positive; then 168 HIV-1 positive samples were detected by BED capture enzyme immunoassay (BED-CEIA) and 17 were positive. Results A total of 787 samples were tested and 168 were HIV-1 positive and 17 were BED- CEIA positive. The prevalence rates of the IDU surveillance sentinel site were 23.06% (92/399) ,21.90% (46/210) and 16. 85% ( 30/178 ), and the incidence rates were 7.41% ( 10/135 ), 6. 94% (5/72) and 3. 12% (2/64) respectively from 2005 to 2007. Conclusion The incidence rate of HIV infections of IDU from a surveillance site of IDU in Guangxi appeared to decline slowly in recent years, and some might have been infected for long time.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2009年第12期1096-1099,共4页 Chinese Journal of Preventive Medicine
关键词 HIV 注射吸毒人群 酶联免疫吸附测定 感染率 HIV Injection drug users (IDU) Enzyme-linked immunosorbent assay Incidence
  • 相关文献

参考文献11

  • 1陆伟江,刘伟,朱秋映,李荣健,梁富雄,黎锋.2002-2007年广西壮族自治区级艾滋病哨点监测报告[J].疾病监测,2009,24(2):103-107. 被引量:18
  • 2Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses,2002 ,18 :295-307.
  • 3韩梅,王豫林,王憨杰,周全华,蒋岩.应用BED—CEIA方法估算重庆市静脉吸毒人群艾滋病病毒感染的发病率[J].中华流行病学杂志,2007,28(11):1077-1080. 被引量:26
  • 4Saphonn V, Parekh BS, Dobbs T, et al. Trends of HIV-1 Seroincidence Among HIV-I Sentinel Surveillance Groups in Cambodia, 1999-2002. J Acquir Immune Defic Syndr, 2005,39 : 587 -592.
  • 5Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA,2008,300:520-529.
  • 6Janssen RS, Satten GA, Strainer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA, 1998,280:4248.
  • 7吕繁,赵金扣,蒋岩,肖瑶,张伟东.BED HIV-1发病监测方法及其应用[J].中国艾滋病性病,2006,12(2):179-181. 被引量:42
  • 8Xiao Y, Jiang Y, Feng J, et al. Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immuno1,2007,14 : 1384-1386.
  • 9沈圣,田飞,江华洲,孙国清,缪礼锋,郭晓黎,肖瑶,贾玉江,Sten H.Vermund,蒋岩.应用BED-CEIA检测干血斑样本监测HIV-1发病率的可行性研究[J].中华流行病学杂志,2009,30(3):273-276. 被引量:12
  • 10Jiang Y, Wang MJ, Ni M, et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS,2007,21 Suppl 8 :S47-51.

二级参考文献51

共引文献85

同被引文献45

  • 1吕繁,赵金扣,蒋岩,肖瑶,张伟东.BED HIV-1发病监测方法及其应用[J].中国艾滋病性病,2006,12(2):179-181. 被引量:42
  • 2中国疾病预防控制中心.艾滋病检测技术规范[EB/OL].[2009-09-01].http://www.edcp.org.cn/flfg/fagui/qgazbjcg.doc.
  • 3Jiang Y, Wang MJ, Ni MJ,et al. HIV-1 incidence esti-mates using IgG-capture BED-enzyme immunoassayfrom surveillance sites of injection drug users in threecities of China[J]. AIDS,2007,21(Suppl 8) :47-51.
  • 4中国疾病预防控制中心.性病艾滋病预防控制中心.HIV-1新发感染血清学方法检测方案[S].中国疾病预防控制中心,2011.
  • 5李新平,邢辉,邵一鸣.HIV-1耐药性表型检测方法研究进展[J].中国艾滋病性病,2007,13(5):486-488. 被引量:6
  • 6WS293-2008.艾滋病和艾滋病病毒感染诊断标准[S].2008.
  • 7Zhao Y,Yu M, Miller JW,et al. Transfuse and human immuno - de-ficiency virus infections [ J ] . Clin Microbiol, 2002,40 ( 2 ) : 675-678.
  • 8Brian L,Mark WP,Ernest W, et al. Use of an acute sero conversionpanel to evaluate at hirdgeneration enzymelinked immunoassay fordetec-tion of human immunodeficiency virus specific antibodies relative tomultiple ot her assays [ J] . Journal of Clinical Microbiology,2006,44 (5) : 1 856 -1 858.
  • 9Tebourski F, Slim A,Elgaaied A. The significance of combiningWorld Health Organization and center for Disease control criteria to re-solve indeterminate human immunodeficiency virus type - 1 Westernblot results [J] . Diagn Microbiol Infect Dis, 2004, 48 (1): 59-61.
  • 10Sudha T, Lakshmi V, Teja VD. Western blot profile in HIV infection[J] . Indian Dermatol Venereol Leprol, 2006, 72 (5 ): 357 -360.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部